EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Gilead Sciences (GILD) Posts Mixed Q1 2025 Results Amidst Product Dynamics
Gilead Sciences (GILD) Lowers 2025 EPS Guidance
Gilead Sciences (GILD) Surpasses Earnings Estimates, Falls Short on Revenue
Gilead Sciences (GILD) Reports Lower-than-Expected Q1 Revenue |
Gilead Sciences Swings to 1Q Profit, But Slashes FY25 EPS Guidance | Morningstar
Intel (INTC) Expected to Report No Change in Earnings | GILD Stock News
Gilead Sciences (GILD) Sees Increased Options Activity Ahead of Earnings | GILD Stock News
Gilead Swings To Profit In Q1 As R&D Charges Ease
Stocks on the Move: Merck, Gilead Sciences, P&G, PG&E Corp, Adobe and the URNM
Coppell Advisory Solutions LLC Has $3.22 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Harvest Investment Services LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
IPG Q1 2025 Earnings Report on 4/24/2025
GLPI Q1 2025 Earnings Report on 4/24/2025
Gilead Sciences (GILD) Earnings Report Preview: Key Insights for Investors
Gilead Sciences (NASDAQ:GILD) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Silverarc Capital Management LLC Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)
CSM Advisors LLC Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Stifel Financial Corp
Correction to Gilead Sciences Veklury Sales Guidance Headline on Feb. 11 | Morningstar
Gilead (GILD) Upgraded to Overweight Amid Positive Outlook for HIV Franchise Growth | AAPL ...
Is Gilead Sciences (GILD) a Cheap NASDAQ Stock to Buy According to Hedge Funds?
Gilead Sciences (GILD) Upgraded by Cantor Fitzgerald with Positive Outlook | GILD Stock News
10,000 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Silverarc Capital Management LLC
J. Safra Sarasin Holding AG Sells 20,537 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Van Lanschot Kempen Investment Management N.V.
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
Gilead Sciences to propel healthcare innovation and cell therapy advancement in Abu Dhabi
Gilead Sciences (GILD) Reports Positive Phase 3 Results for Breast Cancer Treatment | GILD ...
Gilead Sciences (GILD) Surprises with Positive ASCENT-04 Results, Analyst Optimistic | GILD ...
Gilead's (GILD) Trodelvy Shows Promise in Breast Cancer Study
Gilead Sciences Sees Positive Results in Phase 3 Study of Aggressive Breast Cancer | Morningstar
Trodelvy® Plus Keytruda® Demonstrates a Statistically Significan
MetLife Investment Management LLC Buys 6,109 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Curi RMB Capital LLC Has $7.81 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences Reports Positive Data From Phase 3 ASCENT-04/KEYNOTE-D19 Study
4,185 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Gabelli Funds LLC
Gilead Sciences, Inc. (NASDAQ:GILD) Position Reduced by Jump Financial LLC
Analysts' Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) | Markets Insider
Natixis Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by BI Asset Management Fondsmaeglerselskab A S
Capital International Inc. CA Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital World Investors
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dimensional Fund Advisors LP
Gilead Sciences Inc. Purchases New Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)
2,008,338 Shares in Ikena Oncology, Inc. (NASDAQ:IKNA) Purchased by Gilead Sciences Inc.
16,707,477 Shares in Galapagos NV (NASDAQ:GLPG) Bought by Gilead Sciences Inc.
Gilead Sciences Inc. Invests $19.03 Million in Merus (NASDAQ:MRUS)
6,720,803 Shares in Arcellx, Inc. (NASDAQ:ACLX) Bought by Gilead Sciences Inc.
Gilead Sciences Inc. Acquires New Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)
231,663 Shares in Agenus Inc. (NASDAQ:AGEN) Acquired by Gilead Sciences Inc.
Gilead Sciences Inc. Acquires Shares of 4,854,443 Tango Therapeutics, Inc. (NASDAQ:TNGX)
2,209,471 Shares in Assembly Biosciences, Inc. (NASDAQ:ASMB) Acquired by Gilead Sciences Inc.
Edgar Lomax Co. VA Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Forum Financial Management LP
Freedom Investment Management Inc. Sells 2,713 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Capital International Ltd. CA Sells 18,042 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Cadence Bank Sells 114,867 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital International Sarl
Capital Research Global Investors Has $5.35 Billion Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Natixis Has $24.96 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Norinchukin Bank The Grows Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Belmont Capital LLC Has $869,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital Group Investment Management PTE. LTD.
NewEdge Advisors LLC Increases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lessened by Insigneo Advisory Services LLC
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Analysts
Arvest Bank Trust Division Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences Inc. Invests $447.61 Million in Arcus Biosciences, Inc. (NYSE:RCUS)
Gilead Sciences Inc. Invests $461.73 Million in Galapagos NV (NASDAQ:GLPG)
CANADA LIFE ASSURANCE Co Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences Inc. Buys Shares of 1,156,689 Allogene Therapeutics, Inc. (NASDAQ:ALLO)
5,319,148 Shares in Leap Therapeutics, Inc. (NASDAQ:LPTX) Purchased by Gilead Sciences Inc.
Canada Pension Plan Investment Board Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Marshall Wace LLP Has $112.40 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 2,500 Shares of Stock
Zacks Investment Management Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader ...
United Capital Financial Advisors LLC Decreases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Biomedical HIV Prevention Summit in Atlanta Is the Focus To Drive Meaningful Action With Gilead Sciences
Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dodge & Cox
Guggenheim Capital LLC Sells 34,237 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Belpointe Asset Management LLC Buys 4,433 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Synovus Financial Corp Trims Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences Inc (GILD) Advances Oncology Care Through Research Scholars Program | GILD ...
Gilead Sciences: Advancing Oncology Care Through Gilead's Research Scholars Program
Canada Post Corp Registered Pension Plan Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Rossby Financial LCC Invests $232,000 in Gilead Sciences, Inc. (NASDAQ:GILD)
CreativeOne Wealth LLC Buys 9,105 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Mariner LLC
Gilead Sciences (NASDAQ:GILD) Shares Acquired Rep. Jefferson Shreve
Rep. Josh Gottheimer Buys Gilead Sciences, Inc. (NASDAQ:GILD) Shares
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)
Stamos Capital Partners L.P. Sells 19,510 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Sterling Capital Management LLC Purchases 42,040 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Latest news
How will tariffs affect forex: EUR/USD pair weakens amid trade uncertainty
Exchange Traded Funds News: Tech-Focused ETFs Gain Traction Amid AI Boom
Popular CFD trading platforms 2025: eToro, Plus500, IG, MT4, MT5 and more
Hang Seng Index Gains on Strong China GDP amid Trump Tariffs Uncertainty
